References
- Beckford AP, Kaschula ROC, Stephen C. Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J. 1985 Dec 7;68(12):858–863.
- Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, Shieh WJ, Rota PA. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis. 2005 Nov 15;192(10):1686–1693. https://doi.org/10.1086/497169
- Bugvi AS, Rahat R, Zakar R, Zakar MZ, Fischer F, Nasrullah M, Manawar R. Factors associated with non-utilization of child immunization in Pakistan: evidence from the Demographic and Health Survey 2006–07. BMC Public Health. 2014 Dec;14(1):232. https://doi.org/10.1186/1471-2458-14-232
- CDC. Progress toward regional measles elimination-worldwide 2000–2017. Atlanta (USA): Centers for Disease Control and Prevention; 2018.
- De Serres G, Boulianne N, Defay F, Brousseau N, Benoît M, Lacoursière S, Guillemette F, Soto J, Ouakki M, Ward BJ, et al. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12–14 months versus 15 months of age. Clin Infect Dis. 2012 Aug 1;55(3):394–402. https://doi.org/10.1093/cid/cis439
- de Vries RD, McQuaid S, van Amerongen G, Yüksel S, Verburgh RJ, Osterhaus ADME, Duprex WP, de Swart RL. Measles immune suppression: lessons from the macaque model. PLoS Pathog. 2012 Aug 30;8(8):e1002885. https://doi.org/10.1371/journal.ppat.1002885
- Filia A, Bella A, Rota M, Tavilla A, Magurano F, Baggieri M, Nicoletti L, Iannazzo S, Pompa M, Declich S. Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal. Euro Surveill. 2013 May 16;18(20):20480.
- Gaafar T, Moshni E, Lievano F. The challenge of achieving measles elimination in the Eastern Mediterranean Region by 2010. J Infect Dis. 2003;187(Supplement_1):S164–S171. https://doi.org/10.1086/368035
- Hussain S, Yasir M, Tarar SH, Sabir MUD. Measles: demographic profile and associated morbidities of measles cases admitted in a teaching hospital. Pak Armed Forces Med J. 2016;66(1):92–97.
- Islam A, Younas Z, Qadri KFI, Alelwani W, Rauf M, Qadri I. The Battle against measles in Pakistan – the current scenario. 1–2. New York (USA): Crimson Publisher; 2019.
- Khan I, Khattak AA, Muhammad A. Complications of measles in hospitalized children. KMUJ-Khyber Med Univ J. 2013;5(1):27–30.
- Khan T, Qazi J. Measles outbreaks in Pakistan: causes of the tragedy and future implications. Epidemiol Rev. 2014;2(1):1.
- Li J, Zhao Y, Liu Z, Zhang T, Liu C, Liu X. Clinical report of serious complications associated with measles pneumonia in children hospitalized at Shengjing hospital, China. J Infect Dev Ctries. 2015 Oct 29;9(10):1139–1146. https://doi.org/10.3855/jidc.6534
- Mere MO, Goodson JL, Chandio AK, Rana MS, Hasan Q, Teleb N, Alexander JP Jr. Progress toward measles elimination – Pakistan, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019 Jun 07;68(22): 505–510. https://doi.org/10.15585/mmwr.mm6822a4
- Rashid MA, Afridi MI, urRehman MA. Frequency of complications in measles patients at Peshawar. Gomal J Med Sci. 2016;14(2): 112–116.
- Saeed A, Butt ZA, Malik T. Investigation of measles outbreak in a district of Balochistan province, Pakistan. J Ayub Med Coll Abbottabad. 2015 Oct-Dec;27(4):900–903.
- Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, Strebel P. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012 Jun;379(9832):2173–2178. https://doi.org/10.1016/S0140-6736(12)60522-4
- Sultana A, Sabir SA, Awan A. Characteristics of patients with measles admitted to Allied hospital Rawalpindi. J Ayub Med Coll Abbottabad. 2015;27(2):318–322.
- WHO. Measles fact sheet. WHO Updated. No. 286. Geneva (Switzerland): World Health Organization; 2013. [cited 2020 Jan 20]. Available from: http://www.who.int/mediacentre/factsheets/fs286/en/index.html
- WHO. Measles fact sheet. Geneva (Switzerland): World Health Organization; 2016. [cited 2020 Jan 20]. Available from: http://www.who.int/topics/measles/en/
- WHO. Manual for the laboratory-based surveillance of measles, rubella, and congenital rubella syndrome, 3rd edition. Geneva (Switzerland): World Health Organization; 2018a. [cited 2020 Jan 20]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/laboratory/manual/en/
- WHO. Vaccine preventable disease surveillance standards. Measles. Geneva (Switzerland): World Health Organization; 2018b. p. 1–30.
- WHO. Measles and rubella surveillance data, latest updates. Geneva (Switzerland): World Health Organization; 2019. [cited 2020 Jan 20]. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/
- Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol. 2009 Feb 01;38(1): 192–205. https://doi.org/10.1093/ije/dyn224
- Xavier AR, Rodrigues TS, Santos LS, Lacerda GS, Kanaan S. Clinical, laboratorial diagnosis and prophylaxis of measles in Brazil. J Bras Patol Med Lab. 2019;55(4):390–401. https://doi.org/10.5935/1676-2444.20190035